Lobbyist · LDA.gov number 145804

ALANNA TEMME

22 reportsConfirmed from the official record

ALANNA TEMME is named as a lobbyist in 22 lobbying reports we hold, filed by 1 registrant for 22 clients.

Every lobbyist

Earlier government jobs, as reported

A lobbying report lists each lobbyist's covered positions: jobs in Congress or the executive branch that the law asks a lobbyist to disclose. Each line is copied as a report states it.

  • Legislative Director, U.S. Representative Jon Porter

Registrants and clients

Clients: ALKERMES, INC.; ALNYLAM PHARMACEUTICALS, INC.; ARDELYX, INC.; AVADEL PHARMACEUTICALS, PLC; BICYCLE THERAPEUTICS; ERISA INDUSTRY COMMITTEE (ERIC); GLAXOSMITHKLINE LLC; HARMONY BIOSCIENCES; INCYTE CORPORATION; INSMED INCORPORATED; IONIS PHARMACEUTICALS, INC.; MEDICAL DEVICE MANUFACTURERS ASSOCIATION; MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA); NATERA, INC.; NEUROPACE, INC.; PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA; PTC THERAPEUTICS, INC.; REGENXBIO INC.; REZOLUTE, INC.; SAVARA INC.; STEALTH BIOTHERAPEUTICS INC.; UNIVERSITY OF LOUISVILLE HEALTH.

Bills named where this lobbyist is listed, and how the House and the Senate voted

13 bills named in these reports. None of them became law in our record, so no recorded vote is shown. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.

Bills named in reports that list ALANNA TEMME
BillStatusHow the House and the Senate voted
H.R. 946ORPHAN Cures ActIntroducedNo recorded vote in our record
H.R. 1262Mikaela Naylon Give Kids a Chance ActPassed the HouseNo recorded vote in our record
H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.IntroducedNo recorded vote in our record
H.R. 1672Maintaining Investments in New Innovation ActIntroducedNo recorded vote in our record
H.R. 1691Employee Business Expense Deduction Reinstatement Act of 2025IntroducedNo recorded vote in our record
H.R. 2213Medical Supply Chain Resiliency ActIntroducedNo recorded vote in our record
H.R. 4692MAMDANI ActIntroducedNo recorded vote in our record
H.R. 5269RESULTS ActIntroducedNo recorded vote in our record
S. 574Healthy Poultry Assistance and Indemnification Act of 2025IntroducedNo recorded vote in our record
S. 832EPIC Act of 2025IntroducedNo recorded vote in our record
S. 932Give Kids a Chance Act of 2025IntroducedNo recorded vote in our record
S. 1862ORPHAN Cures ActIntroducedNo recorded vote in our record
S. 2355Patients Deserve Price Tags ActReported by committeeNo recorded vote in our record

Issues named: Health Issues (13), Pharmacy (10), Medicare/Medicaid (7), Trade (domestic/foreign) (2).

Every report

Lobbying reports that name ALANNA TEMME
ClientRegistrantKind, as filedPostedReport
INSMED INCORPORATEDTrade (domestic/foreign)LMH STRATEGIC SOLUTIONS2nd Quarter - ReportThe report on LDA.gov
REZOLUTE, INC.Health IssuesLMH STRATEGIC SOLUTIONS2nd Quarter - ReportThe report on LDA.gov
UNIVERSITY OF LOUISVILLE HEALTHMedicare/MedicaidLMH STRATEGIC SOLUTIONS2nd Quarter - ReportThe report on LDA.gov
STEALTH BIOTHERAPEUTICS INC.Health Issues, PharmacyLMH STRATEGIC SOLUTIONS2nd Quarter - ReportThe report on LDA.gov
SAVARA INC.Health Issues, PharmacyLMH STRATEGIC SOLUTIONS2nd Quarter - ReportThe report on LDA.gov
REGENXBIO INC.Health Issues, PharmacyLMH STRATEGIC SOLUTIONS2nd Quarter - ReportThe report on LDA.gov
PTC THERAPEUTICS, INC.Health IssuesLMH STRATEGIC SOLUTIONS2nd Quarter - ReportThe report on LDA.gov
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAPharmacy, Trade (domestic/foreign)LMH STRATEGIC SOLUTIONS2nd Quarter - ReportThe report on LDA.gov
NEUROPACE, INC.Medicare/MedicaidLMH STRATEGIC SOLUTIONS2nd Quarter - ReportThe report on LDA.gov
NATERA, INC.Medicare/MedicaidLMH STRATEGIC SOLUTIONS2nd Quarter - ReportThe report on LDA.gov
MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA)Pharmacy, Medicare/MedicaidLMH STRATEGIC SOLUTIONS2nd Quarter - ReportThe report on LDA.gov
MEDICAL DEVICE MANUFACTURERS ASSOCIATIONHealth Issues, Medicare/MedicaidLMH STRATEGIC SOLUTIONS2nd Quarter - ReportThe report on LDA.gov
IONIS PHARMACEUTICALS, INC.Health IssuesLMH STRATEGIC SOLUTIONS2nd Quarter - ReportThe report on LDA.gov
INCYTE CORPORATIONHealth Issues, PharmacyLMH STRATEGIC SOLUTIONS2nd Quarter - ReportThe report on LDA.gov
HARMONY BIOSCIENCESHealth IssuesLMH STRATEGIC SOLUTIONS2nd Quarter - ReportThe report on LDA.gov
GLAXOSMITHKLINE LLCHealth Issues, PharmacyLMH STRATEGIC SOLUTIONS2nd Quarter - ReportThe report on LDA.gov
ERISA INDUSTRY COMMITTEE (ERIC)Health IssuesLMH STRATEGIC SOLUTIONS2nd Quarter - ReportThe report on LDA.gov
BICYCLE THERAPEUTICSHealth Issues, PharmacyLMH STRATEGIC SOLUTIONS2nd Quarter - ReportThe report on LDA.gov
AVADEL PHARMACEUTICALS, PLCPharmacyLMH STRATEGIC SOLUTIONS2nd Quarter - ReportThe report on LDA.gov
ARDELYX, INC.Health Issues, PharmacyLMH STRATEGIC SOLUTIONS2nd Quarter - ReportThe report on LDA.gov
ALNYLAM PHARMACEUTICALS, INC.Medicare/MedicaidLMH STRATEGIC SOLUTIONS2nd Quarter - ReportThe report on LDA.gov
ALKERMES, INC.Medicare/MedicaidLMH STRATEGIC SOLUTIONS2nd Quarter - ReportThe report on LDA.gov

Campaign gifts this lobbyist reported

Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.

No contribution report we hold lists a gift from this filer.

Where this comes from

Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .

2026-Q2: every page of LDA.gov's list saved and read.

A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.

Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.

Suggest a tool

Suggest a tool

A person reads each idea before it appears. Links are not accepted. Do not include personal information.

See all ideas and vote